CLL: Update on Approved TKIs - 100004


CLL: Update on Approved TKIs

imedex has 1322 videos Subscribe Here

Description: In this presentation from "Lymphoma and Myeloma 2015: An International Congress on Hematologic Malignancies", Dr. Kanti Rai discuses the most recently approved tyrosine-kinase inhibitors (TKIs) for the treatment of chronic lymphocytic leukemia (CLL).

A continuing education program is offered as a supplement to this webcast at the following location:

© 2016 Imedex, LLC.
Shared By : imedex
Posted on : 05/21/16
Added : 3 years ago